SABR for T1-2a N1 NSCLC
NCT03321760
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Decided not to open the study.
Conditions
Lung Cancer
Interventions
RADIATION:
Stereotactic Ablative Radiation Therapy (SABR)
Sponsor
Indiana University